Stay updated on ARO-APOC3 in Mixed Dyslipidemia Clinical Trial

Sign up to get notified when there's something new on the ARO-APOC3 in Mixed Dyslipidemia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ARO-APOC3 in Mixed Dyslipidemia Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3 from the page.
    Difference
    0.0%
    Check dated 2026-03-20T05:19:06.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.0%
    Check dated 2026-03-05T19:47:13.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Results were posted on 2026-02-24 and the study record was updated to reflect the new title 'Study of Plozasiran (ARO-APOC3) in Adults With Mixed Dyslipidemia (MUIR)' with expanded design details and endpoints.
    Difference
    5%
    Check dated 2026-02-26T14:41:23.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Results status changed from 'No Results Posted' to 'Results Submitted', indicating that study results have been submitted. The page revision updated from v3.4.1 to v3.4.2.
    Difference
    0.1%
    Check dated 2026-02-12T02:11:25.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.0 to v3.4.1.
    Difference
    0.0%
    Check dated 2026-02-05T01:27:48.000Z thumbnail image
  9. Check
    68 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option and labels 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' with revision 3.4.0; removed the older labels 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data' with revision 3.3.4.
    Difference
    0.2%
    Check dated 2026-01-28T21:46:26.000Z thumbnail image

Stay in the know with updates to ARO-APOC3 in Mixed Dyslipidemia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ARO-APOC3 in Mixed Dyslipidemia Clinical Trial page.